Xcout Intel
BioCollective, LLC
BioCollective, LLC provides products and services for microbiome research, serving researchers, academic institutions, and biotechnology companies. The company offers patented fecal collection kits, standardized reference samples, a fecal sample bank with diverse population data, and computational metabolic modeling services to support multi-omic analysis and product development.
Subscribe to see BioCollective, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BioCollective, LLC at a glance
BioCollective, LLC is a biotechnology company headquartered in United States. It has raised at least $1.3M across the 2 funding rounds on record. Its most recent funding round raised $1M in May 2016. Xcout tracks 3 named people at BioCollective, LLC, including Dr. Raul Cano, PhD (Chief Scientific Officer).
BioCollective, LLC leadership
- Dr. Raul Cano, PhDChief Scientific Officer
- Martha CarlinFounder & Chief Executive Revolutionary
- Dr. Suzanne Vernon, PhDCo-founder Research Liaison
BioCollective, LLC funding rounds
At least $1.3M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $1M | — | |
| SEC Form D filing | $250,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
BioCollective, LLC competitors
A few of BioCollective, LLC's closest competitors — see the full list of competitors and alternatives →
Organoid Therapeutics, Inc. is a biotechnology contract research organization (CRO) that provides human brain tissue models, neuronal phenotyping, drug screening, and machine learning-based analytical services. The company serves pharmaceutical, biotech, and academic researchers by conducting pre-clinical research and translational studies to evaluate drug efficacy, neurotoxicity, and neurological disease models.
BICO provides lab automation software, instruments, biomaterials, and liquid handling solutions for life science research, drug discovery, and tissue engineering. The company serves pharmaceutical companies, biotechnology firms, and academic institutions by automating laboratory workflows and providing 3D bioprinting and imaging technologies.
Petrichor Bio builds fabless wet labs designed specifically for frontier AI labs to address data constraints in biological research. The company provides specialized biological data and infrastructure to support advancements in AI-driven biology.
Biocytogen provides fully human antibody discovery services and preclinical contract research organization (CRO) services. The company offers genetically engineered animal models, cell lines, gene editing services, and in vivo and in vitro pharmacology studies to support biopharmaceutical research and drug development.
genOway provides preclinical models and custom research solutions, including genetically modified mice, rats, and cell lines, to biopharmaceutical and academic researchers. The company specializes in creating tools such as humanized and conditional knockout models to support efficacy, safety, and pharmacokinetic assessments in drug discovery.
Get BioCollective, LLC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on BioCollective, LLC in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access